Expression of CD40 ligand (CD154) in B and T lymphocytes of Hodgkin disease: Potential therapeutic significance

Cancer

Volumn 94, Issue 1, 2002, Pages 1-5

  Clodi, Katharina ^a   Asgari, Zahra ^b   Younes, Mamoun ^c   Palmer, J Lynn ^b   Cabanillas, Fernando ^b   Carbone, Antonino ^d   Andreeff, Michael ^b   Younes, Anas ^b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

B lymphocytes; CD154; CD40; Reed Sternberg cells

Indexed keywords

ANTIGEN; CD153 ANTIGEN; CD30 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTER; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REED STERNBERG CELL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANTIGENS, CD40; B-LYMPHOCYTES; CD40 LIGAND; CELL SEPARATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0036143638     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10164     Document Type: Article

References (20)

1. Hodgkin's disease: Biology and origin of Hodgkin and Reed-Sternberg cells
2. CD30/CD30 ligand and CD40/CD40 ligand in malignant lymphoid disorders
3. Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines
4. The role of chemokines in Hodgkin's disease
5. Hodgkin's disease: A cytokine-producing tumor - A review
6. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF
7. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells
8. Hodgkin disease: Pharmacologic intervention of the CD40-NFkappaB pathway by a protease inhibitor
9. The nature of Reed-Sternberg cells: Phenotype, genotype, and other properties
10. CD30 ligand is expressed on resting normal and malignant human B lymphocytes
11. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease
12. Coexpression of CD40 and CD40 ligand in B-cell lymphoma cells
13. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type co-stimulatory capacity
14. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukaemia
15. Growth inhibition of follicular small-cleaved-cell lymphoma cells in short-term culture by interleukin-3
16. Fas ligand expression in esophageal carcinomas and their lymph node metastases
17. CD40-CD40 ligand
18. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease
19. CD30 ligand is frequently expressed in human hematopoietic malignancies of myeloid and lymphoid origin
20. CD30 ligand in lymphoma patients with CD30+ tumors